The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending

New England Journal of Medicine

Volumn 349, Issue 23, 2003, Pages 2224-2232

  Huskamp, Haiden A ^a   Deverka, Patricia A ^d   Epstein, Arnold M ^b,c   Epstein, Robert S ^d   McGuigan, Kimberly A ^d   Frank, Richard G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Medco Health Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR;

ARTICLE; DRUG COST; DRUG FORMULARY; DRUG UTILIZATION; DRUG WITHDRAWAL; EMPLOYER; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; UTILIZATION REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COST SHARING; DRUG COSTS; DRUG UTILIZATION REVIEW; DRUGS, GENERIC; FORMULARIES; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSURANCE BENEFITS; INSURANCE, PHARMACEUTICAL SERVICES; MULTIVARIATE ANALYSIS; PRESCRIPTION FEES; PROTON PUMPS; UNITED STATES;

EID: 0344874658     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMsa030954     Document Type: Article

References (17)

1. Gabel J, Levitt L, Holve E, et al. Job-based health benefits in 2002: some important trends. Health Aff (Millwood) 2002;21(5):143-51.
2. Kaiser Family Foundation and Health Research and Educational Trust. Employer health benefits: 2002 summary of findings. (Accessed November 13, 2003, at http://www.kff.org/content/2002/20020905a/3252a.pdf.)
3. Frank R. Prescription drug prices: why do some pay more than others do? Health Aff(Millwood) 2001;20(2):115-28.
4. Description and analysis of the VA national formulary. Blumenthal D, Herdman R, eds. Washington, D.C.: National Academy Press, 2000.
5. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care 2001;39:1293-304.
6. Motheral BR, Henderson R, The effect of a closed formulary on prescription drug use and costs. Inquiry 1999/2000;36:481-91.
7. Huskamp HA, Epstein AM, Blumenthal D. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare? Health Aff (Millwood) 2003;22(3):149-58.
8. Horn SD, Sharkey PD, Phillips-Harris C. Formulary limitations and the elderly: results from the Managed Care Outcomes Project. Am J Manag Care 1998;4:1105-13.
9. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA 2002;288:1733-9. [Erratum, JAMA 2002;288:2409.]
10. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA 2002;288:1733-9. [Erratum, JAMA 2002;288:2409.]
11. Thomas CP, Wallack SS, Lee S, Ritter GA. Impact of health plan design and management on retirees' prescription drug use and spending. (Accessed October 6, 2003, at http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.408v1.pdf.)
12. Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS. Effect of tiered prescription copayments on the use of preferred brand medications. Med Care 2003;41:398-406.
13. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
14. Cook TD, Campbell DT. Quasi-experimentation: design & analysis issues for field settings. Chicago: Rand McNally College Publishing, 1979.
15. Manning WG, Newhouse JP, Duan N, Keeler EB, Leibowitz A, Marquis MS. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev 1987;77:251-77.
16. Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. In: Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley: University of California Press, 1967:221-33.
17. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48:817-30.